These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35382645)

  • 1. Impact of low- and high-risk operators handling irinotecan on the blood contamination of health care workers in oncology day care units.
    Pirot C; Benoist H; Lagadu S; Delépée R; Saint-Lorant G
    J Oncol Pharm Pract; 2023 Jun; 29(4):905-911. PubMed ID: 35382645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does equipment change impact blood contamination with irinotecan and its two major metabolites in a centralized cytotoxic pharmacy unit?
    Benoist H; Breuil C; Le Neindre B; Delépée R; Saint-Lorant G
    J Oncol Pharm Pract; 2020 Dec; 26(8):1823-1828. PubMed ID: 32075506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood contamination of the pharmaceutical staff by irinotecan and its two major metabolites inside and outside a compounding unit.
    Béchet V; Benoist H; Beau F; Divanon F; Lagadu S; Sichel F; Delépée R; Saint-Lorant G
    J Oncol Pharm Pract; 2022 Jun; 28(4):777-784. PubMed ID: 33878975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UHPLC-MS/MS method for the quantification of ultra-traces of irinotecan and its metabolites in red blood cells and plasma to detect caregivers' contamination.
    Rodier S; Saint-Lorant G; Since M; Lagadu S; Benoist H; Palix A; Guilloit JM; Faveyrial A; Divanon F; Delépée R
    Drug Test Anal; 2024 Feb; 16(2):236-246. PubMed ID: 37381704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing the contamination of hospital personnel by cytotoxic agents: evaluation and training of the para-professional healthcare workers in oncology units.
    Kieffer C; Verhaeghe P; Lagrassa S; Grégoire R; Moussaoui Z; Casteras-Ducros C; Clark JE; Vanelle P; Rathelot P
    Eur J Cancer Care (Engl); 2015 May; 24(3):404-10. PubMed ID: 25289934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.
    Acramel A; Fouque J; Blondeel-Gomes S; Huguet S; Rezai K; Madar O; Escalup L
    Ann Work Expo Health; 2022 Nov; 66(9):1215-1223. PubMed ID: 35596678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring surface contamination for thirty antineoplastic drugs: a new proposal for surface exposure levels (SELs).
    Dugheri S; Mucci N; Bucaletti E; Squillaci D; Cappelli G; Trevisani L; Bonari A; Cecchi M; Mini E; Ghiori A; Tognoni D; Berti N; Alderighi F; Li Vigni N; Orlandi I; Arcangeli G
    Med Pr; 2022 Dec; 73(5):383-396. PubMed ID: 36374172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational exposure to cytotoxic drugs: the importance of surface cleaning to prevent or minimise exposure.
    Viegas S; Oliveira AC; Carolino E; Pádua M
    Arh Hig Rada Toksikol; 2018 Sep; 69(3):238-249. PubMed ID: 30285944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs.
    Ursini CL; Cavallo D; Colombi A; Giglio M; Marinaccio A; Iavicoli S
    Int Arch Occup Environ Health; 2006 Nov; 80(2):134-40. PubMed ID: 16761155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface contamination with ten antineoplastic drugs in 83 Canadian centers.
    Chauchat L; Tanguay C; Caron NJ; Gagné S; Labrèche F; Bussières JF
    J Oncol Pharm Pract; 2019 Jul; 25(5):1089-1098. PubMed ID: 29726786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge and practices about safe handling regarding the risk of exposure to antineoplastic drugs for caregivers in compounding units and in operating rooms performing HIPEC/PIPAC.
    Delafoy C; Benoist H; Patin A; Vasseur M; Guillouet S; Eveno C; Guilloit JM; Odou P; Simon N; Saint-Lorant G
    J Oncol Pharm Pract; 2023 Oct; 29(7):1628-1636. PubMed ID: 36514878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.
    Poupeau C; Tanguay C; Plante C; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2017 Jul; 23(5):323-332. PubMed ID: 27084515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.
    Gurusamy KS; Best LM; Tanguay C; Lennan E; Korva M; Bussières JF
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012860. PubMed ID: 29582940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs.
    Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L
    Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental and biological monitoring on an oncology ward during a complete working week.
    Koller M; Böhlandt A; Haberl C; Nowak D; Schierl R
    Toxicol Lett; 2018 Dec; 298():158-163. PubMed ID: 29738807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis to study trends in occupational exposure to antineoplastic drugs among health care workers.
    Sottani C; Porro B; Comelli M; Imbriani M; Minoia C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2593-605. PubMed ID: 20478752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments.
    Dugheri S; Bonari A; Pompilio I; Boccalon P; Mucci N; Arcangeli G
    Arh Hig Rada Toksikol; 2018 Sep; 69(3):226-237. PubMed ID: 30285941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the blood of a surgeon performing HIPEC contaminated by irinotecan, its major metabolites and platinum compounds?
    Saint-Lorant G; Rodier S; Guilloit JM; Ndaw S; Melczer M; Lagadu S; Palix A; Delépée R
    Pleura Peritoneum; 2021 Jun; 6(2):49-55. PubMed ID: 34179338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational Exposure to Antineoplastic Drugs in Twelve French Health Care Setting: Biological Monitoring and Surface Contamination.
    Ndaw S; Remy A
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.